By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Discovery, development and commercialization of innovative targeted protein degradation medicines6.25M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States83.98M100.00%